Literature DB >> 30776671

Grading of hepatocellular carcinoma using 3D SE-DenseNet in dynamic enhanced MR images.

Qing Zhou1, Zhiyong Zhou2, Chunmiao Chen3, Guohua Fan4, Guangqiang Chen4, Haiyan Heng4, Jiansong Ji5, Yakang Dai6.   

Abstract

BACKGROUND: Clinical histological grading of hepatocellular carcinoma (HCC) differentiation is of great significance in clinical diagnoses, treatments, and prognoses. However, it is challenging for radiologists to evaluate HCC gradings from medical images.
PURPOSE: In this study, a novel deep neural network was developed by combining the squeeze-and-excitation networks (SENets) in a three-dimensional (3D) densely connected convolutional network (DenseNet), which is referred to as a 3D SE-DenseNet, for the classification of HCC grading using enhanced clinical magnetic resonance (MR) images obtained from two different clinical centers.
METHOD: In the proposed architecture, the SENet was added as an additional layer between the dense blocks of the 3D DenseNet, to mitigate the impact of feature redundancy. For the HCC grading task, the 3D SE-DenseNet was trained after data augmentation, and it outperformed the 3D DenseNet based on the clinical dataset.
RESULTS: The quantitative evaluations of the 3D SE-DenseNet on a two-class HCC grading task were conducted based on the dataset, which included 213 samples of the dynamic enhanced MR images. The proposed 3D SE-DenseNet demonstrated an accuracy of 83%, when compared with the 72% accuracy of the 3D DenseNet.
CONCLUSION: Owing to the advantage of useful automatic feature learning by the SE layer, the 3D SE-DenseNet can simultaneously handle useful feature enhancement and superfluous feature suppression. The quantitative experiments confirm the excellent performance of the 3D SE-DenseNet in the evaluation of the HCC grading.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  3D DenseNet; Grading; Hepatocellular carcinoma; MRI; SENet

Mesh:

Year:  2019        PMID: 30776671     DOI: 10.1016/j.compbiomed.2019.01.026

Source DB:  PubMed          Journal:  Comput Biol Med        ISSN: 0010-4825            Impact factor:   4.589


  6 in total

Review 1.  Artificial Intelligence for Precision Oncology.

Authors:  Sherry Bhalla; Alessandro Laganà
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 2.  Artificial Intelligence in Cancer Research and Precision Medicine.

Authors:  Bhavneet Bhinder; Coryandar Gilvary; Neel S Madhukar; Olivier Elemento
Journal:  Cancer Discov       Date:  2021-04       Impact factor: 38.272

3.  Classification and mutation prediction based on histopathology H&E images in liver cancer using deep learning.

Authors:  Mingyu Chen; Bin Zhang; Win Topatana; Jiasheng Cao; Hepan Zhu; Sarun Juengpanich; Qijiang Mao; Hong Yu; Xiujun Cai
Journal:  NPJ Precis Oncol       Date:  2020-06-08

Review 4.  Progress of MRI Radiomics in Hepatocellular Carcinoma.

Authors:  Xue-Qin Gong; Yun-Yun Tao; Yao-Kun Wu; Ning Liu; Xi Yu; Ran Wang; Jing Zheng; Nian Liu; Xiao-Hua Huang; Jing-Dong Li; Gang Yang; Xiao-Qin Wei; Lin Yang; Xiao-Ming Zhang
Journal:  Front Oncol       Date:  2021-09-20       Impact factor: 6.244

Review 5.  Artificial intelligence for assisting cancer diagnosis and treatment in the era of precision medicine.

Authors:  Zi-Hang Chen; Li Lin; Chen-Fei Wu; Chao-Feng Li; Rui-Hua Xu; Ying Sun
Journal:  Cancer Commun (Lond)       Date:  2021-10-06

Review 6.  Dense Convolutional Network and Its Application in Medical Image Analysis.

Authors:  Tao Zhou; XinYu Ye; HuiLing Lu; Xiaomin Zheng; Shi Qiu; YunCan Liu
Journal:  Biomed Res Int       Date:  2022-04-25       Impact factor: 3.246

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.